Robert Krause
Impact in
- Hepatology top 2%
- Liver Diseases and Immunity
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
Papers in
-
- COVID-19 Clinical Research Studies 8
- Antifungal resistance and susceptibility 8
- Viral Infections and Vectors 7
- SARS-CoV-2 and COVID-19 Research 7
- Co-authors
- Gabriele BergStefan PilzJohn P. A. IoannidisVerena Theiler‐SchwetzChristian TrummerHanns–Ulrich MarschallKurt ZatloukalAndrea Fuchsbichler
- Journals
- Clinical Microbiology and Infection (3 papers)Frontiers in Microbiology (3 papers)Communications Biology (2 papers)Mycoses (2 papers)Journal of Clinical Microbiology (2 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Robert Krause
103 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Hepatology 314
- Infectious Diseases 625
- Molecular Medicine 138
- Modeling and Simulation 92
- Applied Microbiology and Biotechnology 40
Countries citing papers authored by Robert Krause
This map shows the geographic impact of Robert Krause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Krause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Krause more than expected).
Fields of papers citing papers by Robert Krause
This network shows the impact of papers produced by Robert Krause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Krause. The network helps show where Robert Krause may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Krause, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 107 | |
| 9 | 2021 | 5 | |
| 10 | 2017 | 5 | |
| 11 | 2015 | 20 | |
| 12 | 2014 | 9 | |
| 13 | 2013 | 27 | |
| 14 | 2012 | 10 | |
| 15 | 2011 | 1 | |
| 16 | 2005 | 12 | |
| 17 | 2004 | 39 | |
| 18 | 2003 | 11 | |
| 19 | In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group. | 1999 | 5 |
| 20 | 1976 | 3 |
About Robert Krause
Robert Krause is a scholar working on Microbiology, Infectious Diseases, Parasitology, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 105 papers that have together received 2.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Antifungal resistance and susceptibility (8 papers), Viral Infections and Vectors (7 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (5 papers), Gut microbiota and health (5 papers) and COVID-19 epidemiological studies (5 papers). The work is most often cited by research in Hepatology (314 citations), Infectious Diseases (625 citations), Molecular Medicine (138 citations), Modeling and Simulation (92 citations) and Applied Microbiology and Biotechnology (40 citations). Robert Krause has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Gabriele Berg, Stefan Pilz, John P. A. Ioannidis, Verena Theiler‐Schwetz, Christian Trummer, Hanns–Ulrich Marschall, Kurt Zatloukal, Andrea Fuchsbichler, Peter Fickert and Michael Trauner. Their work appears in journals such as Clinical Microbiology and Infection, Frontiers in Microbiology, Communications Biology, Mycoses and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.